-+ 0.00%
-+ 0.00%
-+ 0.00%

CBIZ REPORT HIGHLIGHTS RISING COSTS: SURGE IN INPATIENT AND OUTPATIENT EXPENSES, POPULAR GLP-1 DRUGS LIKE OZEMPIC DRIVE PHARMACY SPEND INCREASE

Reuters·05/20/2025 13:00:03

Please log in to view news